Pei-Ying Wu

National Cheng Kung University Hospital

Papers

1

Total Citations

10

H-Index

1

About

No biography available yet.

Research Focus

Bevacizumab1 · 10 citations
Cancer1 · 10 citations
Carboplatin1 · 10 citations
Chemotherapy1 · 10 citations
Cisplatin1 · 10 citations
Cohort1 · 10 citations
Confidence interval1 · 10 citations
Hazard ratio1 · 10 citations
Internal medicine1 · 10 citations
Medicine1 · 10 citations
Oncology1 · 10 citations
Ovarian cancer1 · 10 citations

Key Achievements

1
H-Index
1
Papers
10
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Real-World Study of Adding Bevacizumab to Chemotherapy for Ovarian, Tubal, and Peritoneal Cancer as Front-Line or Relapse Therapy (ROBOT): 8-Year Experience
10 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: National Cheng Kung University Hospital

Top Papers

  1. 1
    Real-World Study of Adding Bevacizumab to Chemotherapy for Ovarian, Tubal, and Peritoneal Cancer as Front-Line or Relapse Therapy (ROBOT): 8-Year Experience
    10 citations · 2020

Key Collaborators

YCYi-Chun Chen1 shared papersYCYa-Min Cheng1 shared papersYHYu-Fang Huang1 shared papersMSMeng‐Ru Shen1 shared papersCCCheng-Yang Chou1 shared papers
Not generated yet